Guardant Health (GH) Gross Profit (2024 - 2026)

Guardant Health has disclosed Gross Profit across 3 years of filings, most recently posting $219.0 million for Q2 2026.

• In Q2 2026, Gross Profit rose 45.16% year-over-year to $219.0 million; the TTM figure through Jun 2026 stood at $769.2 million (up 47.68% YoY), while the FY2025 annual figure was $633.0 million, up 40.91% from the prior year.
• Gross Profit came in at $219.0 million for Q2 2026 at Guardant Health, up from $196.7 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $219.0 million in Q2 2026 to a low of $103.2 million in Q1 2024.
• Average Gross Profit over 3 years is $149.8 million, with a median of $139.8 million recorded in 2025.
• Year-over-year, Gross Profit grew 24.76% in 2025 and soared 52.81% in 2026.
• Over 3 years, Gross Profit stood at $124.2 million in 2024, then surged by 46.33% to $181.8 million in 2025, then climbed by 20.5% to $219.0 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $219.0 million in Q2 2026, $196.7 million in Q1 2026, and $181.8 million in Q4 2025.